Charles A. Sanders, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 3,000 shares at $43.86 ($132K) on 2006-12-01, disclosed to the SEC on 2006-12-04.
Scheduled sale ($132k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BIOD | BUY | 2011-08-11 | $12K | — | Filing → |
| BIOD | BUY | 2010-05-13 | $28K | — | Filing → |
| BCRX | BUY | 2010-02-09 | $33K | — | Filing → |